Open Access Open Access  Restricted Access Subscription or Fee Access

Therapeutic Effect of PEGylated Phytosomes Loaded with Herbal Drugs for Treating Paediatric Leukaemia

Sanchita Mandal, Shibangi Mukhopadhyay

Abstract


To treat pediatric leukemia, this study evaluated a co-encapsulated pegylated phytosome system based on herbal anti-cancer medications. In this study, herbal drug-soy lecithin complex-loaded phytosomes were prepared as drug carriers to overcome the limitations of natural drugs like poor absorption, low oral bioavailability, poor aqueous solubility, and so on. This is a targeted nano-drug delivery that enhances the absorption and bioavailability of the herbal drug used. In this study, herbal drug-soy lecithin complex-loaded phytosomes were further surface-functionalized with PEG as drug carriers to overcome these limitations and achieve reduced toxicity and a superior herbal drug-mediated therapeutic effect. PEGylation can help the phytosomes avoid rapid clearance from the systemic circulation by the reticuloendothelial system (RES) and increase their passive targeting effectiveness. To do this, a postinsertion approach was used to inject PEG into the lipid moiety of the phytosomes. The generated PEG-functionalized drug-loaded phytosomes feature spherical shapes, steady zeta potential values, very low PDI values, and sustained drug release while improving the therapeutic action of herbal drugs.


Full Text:

PDF

References


Shah A, Andersson TML, Rachet B, Björkholm M, Lambert PC. Survival and cure of acute myeloid leukaemia in England, 1971–2006: a population-based study. Br J Haematol. 2013; 162(4):509–16. DOI: 10.1111/bjh.12425.

2 De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6(7):e441-. DOI: 10.1038/bcj.2016.50.

Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013;11(3):275–86. DOI: 10.1007/s40258–013–0032–2.

Parikh SA, Jabbour E, Koller CA. Adult acute myeloid leukemia adult acute myeloid leukemia: introduction epidemiology, etiology, and risk factors. In: MD Anderson manual of medical oncology; 2014. p. 1–25.

Hernández C. Leucemia mieloide aguda: diagnóstico, estudio y tratamiento. Manual de prácticas médicas-hospital hermanos ameijeiras. La Habana; 2006.

Pavone V, Riccioli M, Testa G, Lucenti L, De Cristo C, Condorelli G et al. Surgical treatment of displaced supracondylar pediatric humerus fractures: comparison of two pinning techniques. J Funct Morphol Kinesiol. 2016;1(1):39–47. DOI: 10.3390/jfmk1010039.

Majchrzak A, More PHB, Faraj S. Transcending knowledge differences in cross-functional teams. Organ Sci. 2012;23(4):951–70. DOI: 10.1287/orsc.1110.0677.

Tapiero H, Tew KD, Ba GN, Mathé G. Polyphenols: do they play a role in the prevention of human pathologies? Biomed Pharmacother. 2002;56(4):200–7. DOI: 10.1016/s0753–3322(02)00178–6.

Sak K. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev. 2014;8(16):122–46. DOI: 10.4103/0973–7847.134247.

Huang MY, Zhang LL, Ding J, Lu JJ. Anticancer drug discovery from Chinese medicinal herbs. Chin Med. 2018;13(1):35. DOI: 10.1186/s13020–018–0192-y.

Amawi H, Ashby CR, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what’s limiting? Chin J Cancer. 2017; 36(1):50. DOI: 10.1186/s40880–017–0217–4.

Kumar V, Bhatt PC, Rahman M, Kaithwas G, Choudhry H, Al-Abbasi FA, et al. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in the treatment of hepatocellular carcinoma: in vitro and in vivo studies. Int J Nanomedicine. 2017;12:6747–58. DOI: 10.2147/IJN.S136629.

Li Y, Wu H, Jia M, Cui F, Lin J, Yang X et al. Therapeutic effect of folate-targeted and pegylated phytosomes loaded with a Mitomycin C–soybean phosphatidyhlcholine complex. Mol Pharm. 2014;11(9):3017–26. DOI: 10.1021/mp5001873.

Harborne JB. Classes and functions of secondary products from plants. Chem Plants. 1999; 26:

–25.

Kashyap D, Tuli HS, Yerer MB, Sharma A, Sak K, Srivastava S et al. Natural product-based nanoformulations for cancer therapy: opportunities and challenges. Semin Cancer Biol. 2021, February;69. DOI: 10.1016/j.semcancer.2019.08.014.

Ahmed E, Arshad M, Khan MZ, Amjad MS, Sadaf HM, Riaz I, et al. Secondary metabolites and their multidimensional prospective in plant life. J Pharmacogn Phytochem. 2017; 6(2):205–14.

Pandey P, Rahman M, Bhatt PC, Beg S, Paul B, Hafeez A, et al. Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin. Nanomedicine (Lond). 2018; 13(8):849–70. DOI: 10.2217/nnm-2017–0306.

Zare-Zardini H, Alemi A, Taheri-Kafrani A, Hosseini SA, Soltaninejad H, Hamidieh AA et al. Assessment of a new ginsenoside Rh2 nanoniosomal formulation for enhanced antitumor efficacy on prostate cancer: an in vitro study. Drug Des Dev Ther. 2020; 14:3315–24. DOI: 10.2147/DDDT.S261027.

Dave V, Gupta A, Singh P, Gupta C, Sadhu V, Reddy KR. Synthesis and characterization of celecoxib loaded pegylated liposome nanoparticles for biomedical applications. Nano Struct Nano Objects. 2019; 18:100288. DOI: 10.1016/j.nanoso.2019.100288.

El-Far SW, Helmy MW, Khattab SN, Bekhit AA, Hussein AA, Elzoghby AO. Folate conjugated vs pegylated phytosomal casein nanocarriers for codelivery of fungal- and herbal-derived anticancer drugs. Nanomedicine (Lond). 2018; 13(12):1463–80. DOI: 10.2217/nnm-2018–0006.

Shah NB, Vercellotti GM, White JG, Fegan A, Wagner CR, Bischof JC. Blood–nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Mol Pharm. 2012;9(8):2146–55. DOI: 10.1021/mp200626j.

Kesharwani P, Gorain B, Low SY, Tan SA, Ling ECS, Lim YK et al. Nanotechnology based approaches for anti-diabetic drugs delivery. Diabetes Res Clin Pract. 2018; 136:52–77. DOI: 10.1016/j.diabres.2017.11.018.

Rajendran I, Dhandapani H, Anantanarayanan R, Rajaram R. Apigenin mediated gold nanoparticle synthesis and their anti-cancer effect on human epidermoid carcinoma (A431) cells. RSC Adv. 2015;5(63):51055–66. DOI: 10.1039/C5RA04303D.

Suresh K, Nangia A. Curcumin: pharmaceutical solids as a platform to improve solubility and bioavailability. CrystEngComm. 2018; 20(24):3277–96. DOI: 10.1039/C8CE00469B.

Jantová S, Cipák L, Cernáková M, Kost’álová D. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol. 2003;55(8):1143–9. DOI: 10.1211/002235703322277186.

Liu CS, Zheng YR, Zhang YF, Long XY. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia. 2016; 109:274–82. DOI: 10.1016/j.fitote.2016.02.001.

Ayesa U, Gray BD, Pak KY, Chong PLG. Liposomes containing lipid-soluble Zn(II)–bis-dipicolylamine derivatives show potential to be targeted to phosphatidylserine on the surface of cancer cells. Mol Pharm. 2017;14(1):147–56. DOI: 10.1021/acs.molpharmaceut.6b00760.

Williams J, Lansdown R, Sweitzer R, Romanowski M, LaBell R, Ramaswami R et al. Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J Control Release. 2003;91(1–2):167–72. DOI: 10.1016/s0168–3659(03)00241–4.

Thangapazham RL, Puri A, Tele S, Blumenthal R, Maheshwari RK. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol. 2008;32(5):1119–23. DOI: 10.3892/ijo.32.5.1119.

Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009; 29(10):3867–75.

Li J, Wang Y, Yang C, Wang P, Oelschlager DK, Zheng Y et al. Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol Pharmacol. 2009; 76(1):81–90. DOI: 10.1124/mol.109.054551.

Zu YG, Yuan S, Zhao XH, Zhang Y, Zhang XN, Jiang R. Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles. Yao Xue Xue Bao. 2009; 44(5): 525–31.

Ban E, Park M, Jeong S, Kwon T, Kim EH, Jung K et al. Poloxamer-based thermoreversible gel for topical delivery of emodin: influence of P407 and P188 on solubility of emodin and its application in cellular activity screening. Molecules. 2017; 22(2):246. DOI: 10.3390/molecules22020246.

Chen R, Wang S, Zhang J, Chen M, Wang Y. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study. Drug Deliv. 2015; 22(5):666–74. DOI: 10.3109/10717544.2014.882446.

Agarawal K, Anant Kulkarni Y, Wairkar S. Nanoformulations of flavonoids for diabetes and microvascular diabetic complications. Drug Deliv Transl Res. 2023; 13(1):18–36. DOI: 10.1007/s13346–022–01174-x.

Mukherjee B, Banerjee S, Mondal L, Chakraborty S, Chanda D, Perera JAC. Bioactive flavonoid apigenin and its nanoformulations: a promising hope for diabetes and cancer. In: Nanomedicine for bioactives. Singapore: Springer; 2020. p. 367–82.

Wang X, Wang Y. Ginsenoside Rh2 mitigates pediatric leukemia through suppression of Bcl-2 in leukemia cells. Cell Physiol Biochem. 2015;37(2):641–50. DOI: 10.1159/000430383.

Jin S, Fu S, Han J, Jin S, Lv Q, Lu Y et al. Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles. J Drug Target. 2012;20(7):615–22. DOI: 10.3109/1061186X.2012.702770.

Mishra D, Jain N, Rajoriya V, Jain AK. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine. J Pharm Pharmacol. 2014; 66(8):1082–93. DOI: 10.1111/jphp.12235.

Gera S, Talluri S, Rangaraj N, Sampathi S. Formulation and evaluation of naringenin nanosuspensions for bioavailability enhancement. AAPS PharmSciTech. 2017; 18(8):3151–62. DOI: 10.1208/s12249–017–0790–5.

Taghipour YD, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A et al. Nanoformulations of natural products for management of metabolic syndrome. Int J Nanomedicine. 2019;14:5303–21. DOI: 10.2147/IJN.S213831.

Figueiró F, Bernardi A, Frozza RL, Terroso T, Zanotto-Filho A, Jandrey EH et al. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J Biomed Nanotechnol. 2013;9(3):516–26. DOI: 10.1166/jbn.2013.1547.

Wang J, Li G, Rui T, Kang A, Li G, Fu T et al. Pharmacokinetics of rosmarinic acid in rats by LC-MS/MS: absolute bioavailability and dose proportionality. RSC Adv. 2017; 7(15):9057–63. DOI: 10.1039/C6RA28237G.

El-Far YM, Zakaria MM, Gabr MM, El Gayar AM, El-Sherbiny IM, Eissa LA. A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes. Nanomedicine (Lond). 2016; 11(19):2581–602. DOI: 10.2217/nnm-2016–0204.

Ochi MM, Amoabediny G, Rezayat SM, Akbarzadeh A, Ebrahimi B. In vitro co-delivery evaluation of novel pegylated nano-liposomal herbal drugs of silibinin and glycyrrhizic acid (nano-phytosome) to hepatocellular carcinoma cells. Cell J. 2016;18(2):135–48. DOI: 10.22074/cellj.2016.4308.

Mukhopadhyay P, Prajapati AK. Quercetin in anti-diabetic research and strategies for improved quercetin bioavailability using polymer-based carriers – a review. RSC Adv. 2015;5(118):97547–62. DOI: 10.1039/C5RA18896B.

Minaei A, Sabzichi M, Ramezani F, Hamishehkar H, Samadi N. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol Biol Rep. 2016;43(2):99–105. DOI: 10.1007/s11033–016–3942-x.

Click ZR, Seddon AN, Bae YR, Fisher JD, Ogunniyi A. New Food and Drug Administration–approved and emerging novel treatment options for acute myeloid leukemia. Pharmacotherapy. 2018;38(11):1143–54. DOI: 10.1002/phar.2180.

Yates JW, Wallace Jr HJ, Ellison RR, Holland JF. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep. 1973; 57(4):485–8.

Kadia TM, Ravandi F, O’Brien S, Cortes J, Kantarjian HM. Progress in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015; 15(3):139–51. DOI: 10.1016/j.clml.2014.08.006.

Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453–74. DOI: 10.1182/blood-2009–07–235358.

Burnett AK, Russell NH, Hills RK, Hunter AE, Kjeldsen L, Yin J et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the Medical Research Council AML15 trial. J Clin Oncol. 2013;31(27):3360–8. DOI: 10.1200/JCO.2012.47.4874.

Borthakur G, Kantarjian H, Wang X, Plunkett Jr WK, Gandhi VV, Faderl S et al. Treatment of core‐binding‐factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event‐free survival. Cancer. 2008;113(11):3181–5. DOI: 10.1002/cncr.23927.

Acheampong DO, Adokoh CK, Asante DB, Asiamah EA, Barnie PA, Bonsu DOM et al. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomed Pharmacother. 2018; 97:225–32. DOI: 10.1016/j.biopha.2017.10.100.

Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):61–73. DOI: 10.1016/j.pcl.2014.09.006.

Siveen KS, Uddin S, Mohammad RM. Targeting acute myeloid leukemia stem cell signaling by natural products. Mol Cancer. 2017;16(1):13. DOI: 10.1186/s12943–016–0571-x.

Huber B, Eberl L, Feucht W, Polster J. Influence of polyphenols on bacterial biofilm formation and quorum-sensing. Z Naturforsch C J Biosci. 2003;58(11–12):879–84. DOI: 10.1515/znc-2003–11–1224.

Karakaya S, Koca M, Yılmaz SV, Yıldırım K, Pınar NM, Demirci B et al. Molecular docking studies of coumarins isolated from extracts and essential oils of zosima absinthifolia link as potential inhibitors for Alzheimer’s disease. Molecules. 2019;24(4):722. DOI: 10.3390/molecules24040722.

Siddique AB, Ebrahim H, Mohyeldin M, Qusa M, Batarseh Y, Fayyad A, et al. Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity. PLOS ONE. 2019;14(4):e0214798. DOI: 10.1371/journal.pone.0214798.

Bombardelli E. Phytosome: new cosmetic delivery system. Boll Chim Farm. 1991; 130(11): 431–8.

Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev. 2009;14(3):226–46.

Bombardelli E, Curri SB, Della Loggia R, Del Negro P, Gariboldi P, Tubaro A. Complexes between phospholipids and vegetal derivates of biological interest; 1989.

Hou Z, Li Y, Huang Y, Zhou C, Lin J, Wang Y, et al. Phytosomes loaded with Mitomycin C–soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm. 2013;10(1):90–101. DOI: 10.1021/mp300489p.

Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935–47. DOI: 10.2147/IJN.S121881.

Wang Y, Tan Y. Enhanced drug loading capacity of 10-hydroxycamptothecin-loaded nanoparticles prepared by two-step nanoprecipitation method. J Drug Deliv Sci Technol. 2016; 36:183–91. DOI: 10.1016/j.jddst.2016.09.012.

Zhang D, Zhang J. Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy. Biomaterials. 2020; 230: 119646. DOI: 10.1016/j.biomaterials.2019.119646.

Dutta A, Patil RK, Pati HCl. Curcumin: its bioavailability and nanoparticle formulation: a review. Int J Health Sci Res. 2021; 11(10):228–38. DOI: 10.52403/ijhsr.20211030.

Mertins K, Iovel I, Kischel J, Zapf A, Beller M. Transition‐metal‐catalyzed benzylation of arenes and heteroarenes. Angew Chem Int Ed Engl. 2004; 44(2):238–42. DOI: 10.1002/anie.200460666.

Rajendar M, Saraswathi B. Preparation and optimization of diclofenac encapsulated liposomes using lipid hydration; 2014.

Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005; 306(1–2):71–82. DOI: 10.1016/j.ijpharm.2005.09.023.

Ko YT, Bickel U. Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique. AAPS Pharm Sci Tech. 2012; 13(2):373–8. DOI: 10.1208/s12249–012–9757–8.

Nele V, Holme MN, Kauscher U, Thomas MR, Doutch JJ, Stevens MM. Effect of formulation method, lipid composition, and pegylation on vesicle lamellarity: a small-angle neutron scattering study. Langmuir. 2019; 35(18):6064–74. DOI: 10.1021/acs.langmuir.8b04256.

Abdel-Fattah M, Saber M, Kantoush SA, Khalil MF, Sumi T, Sefelnasr AM. A hydrological and geomorphometric approach to understanding the generation of wadi flash floods. Water. 2017; 9(7):553. DOI: 10.3390/w9070553.

Telange DR, Patil AT, Pethe AM, Tatode AA, Anand S, Dave VS. Kaempferol-phospholipid complex: formulation, and evaluation of improved solubility, in vivo bioavailability, and antioxidant potential of kaempferol. J Excipients Food Chem. 2016;7(4):1174.

Kesharwani SS, Jain V, Dey S, Sharma S, Mallya P, Kumar VA. An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin. J Drug Deliv Sci Technol. 2020; 60:102021. DOI: 10.1016/j.jddst.2020.102021.

Khan J, Alexander A, Ajazuddin S, Saraf S, Saraf S. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release. 2013; 168(1):50–60. DOI: 10.1016/j.jconrel.2013.02.025.

Hatami A, Heydarinasab A, Akbarzadehkhiyavi A, Shariati FP. In vitro co-delivery evaluation of pegylated nano-liposome loaded by glycyrrhizic acid and cisplatin on cancer cell lines. J Nanopart Res. 2020; 22(9):1–12. DOI: 10.1007/s11051–020–04982–9.

Yu T, Wu C, Zhu C, He Y, Yang D, Cheng Y et al. Oral administration of liposome-apatinib and locally delivery of docetaxel/MPEG-PCL by fibrin glue synergistically improve therapeutic effect in colorectal cancer. J Biomed Nanotechnol. 2018; 14(12):2077–91. DOI: 10.1166/jbn.2018.2651.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506. DOI: 10.1016/S0140–6736(20)30183–5.

Upase AU, Bhusnure OG, Gholve SB, Giram PS, Wattamwar PB. A review on Phytosome loaded with novel herbal drug and their formulation, standardization and applications. J Drug Deliv Ther. 2019; 9(3-s):765–9.

Yu F, Li Y, Liu CS, Chen Q, Wang GH, Guo W, et al. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int J Pharm. 2015; 484(1–2):181–91. DOI: 10.1016/j.ijpharm.2015.02.055.

Ahmad I, Akhter S, Anwar M, Zafar S, Sharma RK, Ali A et al. Supercritical anti-solvent technique assisted synthesis of thymoquinone liposomes for radioprotection: formulation optimization, in-vitro and in-vivo studies. Int J Pharm. 2017; 523(1):398–409. DOI: 10.1016/j.ijpharm.2017.03.052.

Alhakamy NA, A Fahmy U, Badr-Eldin SM, Ahmed OAA, Asfour HZ, Aldawsari HM et al. Optimized icariin phytosomes exhibit enhanced cytotoxicity and apoptosis-inducing activities in ovarian cancer cells. Pharmaceutics. 2020; 12(4):346. DOI: 10.3390/pharmaceutics12040346.

Lesoin L, Crampon C, Boutin O, Badens E. Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method. J Supercrit Fluids. 2011;57(2):162–74. DOI: 10.1016/j.supflu.2011.01.006.

Singh R, Upadhyay AK, Chandra P, Singh DP. Sodium chloride incites reactive oxygen species in green algae Chlorococcum humicola and Chlorella vulgaris: implication on lipid synthesis, mineral nutrients and antioxidant system. Bioresour Technol. 2018; 270:489–97. DOI: 10.1016/j.biortech.2018.09.065.

Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, et al. Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2019;54(4):519–30. DOI: 10.1038/s41409–018–0286–2.

Singh V, Sahebkar A, Kesharwani P. Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery. Eur Polym J. 2021; 158:110683. DOI: 10.1016/j.eurpolymj.2021.110683.

Kesharwani SS, Bhat GJ. Formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of zerumbone. Medicina (Kaunas). 2020;56(11):557. DOI: 10.3390/medicina56110557.

Yu F, Ao M, Zheng X, Li N, Xia J, Li Y et al. PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency. Drug Deliv. 2017; 24(1):825–33. DOI: 10.1080/10717544.2017.1321062.

Seca AML, Pinto DCGA. Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci. 2018; 19(1):263. DOI: 10.3390/ijms19010263.

Zhao QS, Hu LL, Wang ZD, Li ZP, Wang AW, Liu J. Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced antitumor efficacy in non-small cell lung cancers. Mater Sci Eng C Mater Biol Appl. 2017; 72: 185–91. DOI: 10.1016/j.msec.2016.10.077.

Yu F, Li Y, Chen Q, He Y, Wang H, Yang L et al. Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. Eur J Pharm Biopharm. 2016; 103:136–48. DOI: 10.1016/j.ejpb.2016.03.019.




DOI: https://doi.org/10.37591/nanotrends.v24i3.1395

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Nano Trends-A Journal of Nano Technology & Its Applications